TY - JOUR
T1 - Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling
AU - Nagasawa, Motonori
AU - Yamamoto, Koichi
AU - Rakugi, Hiromi
AU - Takeda, Masao
AU - Akasaka, Hiroshi
AU - Umakoshi, Hironobu
AU - Tsuiki, Mika
AU - Takeda, Yoshiyu
AU - Kurihara, Isao
AU - Itoh, Hiroshi
AU - Ichijo, Takamasa
AU - Katabami, Takuyuki
AU - Wada, Norio
AU - Shibayama, Yui
AU - Yoshimoto, Takanobu
AU - Ogawa, Yoshihiro
AU - Kawashima, Junji
AU - Sone, Masakatsu
AU - Inagaki, Nobuya
AU - Takahashi, Katsutoshi
AU - Fujita, Megumi
AU - Watanabe, Minemori
AU - Matsuda, Yuichi
AU - Kobayashi, Hiroki
AU - Shibata, Hirotaka
AU - Kamemura, Kohei
AU - Otsuki, Michio
AU - Fujii, Yuichi
AU - Ogo, Atsushi
AU - Okamura, Shintaro
AU - Miyauchi, Shozo
AU - Yanase, Toshihiko
AU - Suzuki, Tomoko
AU - Kawamura, Takashi
AU - Naruse, Mitsuhide
N1 - Funding Information:
The current study was supported in part by grants-in-aid for the study of primary aldosteronism in Japan (JPAS) and the study of rare adrenal diseases in Japan (JRAS) from the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED) (JP17ek0109122 and JP18ek0109352, respectively) and a grant from the National Center for Global Health and Medicine, Japan (27-1402).
Publisher Copyright:
© 2019 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Objectives:Because of the influence on the renin-angiotensin-aldosterone system, it is recommended to avoid, if possible, the use of angiotensin-converting-enzyme inhibitors, angiotensin II type 1 receptor blockers, diuretics, β-blockers, and mineralocorticoid receptor antagonists during the diagnostic period of primary aldosteronism. A laterality index more than 4 in adrenocorticotropic hormone (ACTH)-stimulated adrenal venous sampling (ACTH-AVS) is a widely used classification of the unilateral subtype that can benefit from adrenalectomy. Here, we revealed clinical features of patients taking drugs that could affect the primary aldosteronism diagnosis (DAPD) and investigated whether the classification with laterality index more than 4 in ACTH-AVS is applicable to these patients.Patients and methods:Using a large database of primary aldosteronism patients in Japan, we analyzed 2122 patients with successful ACTH-AVS.Results:Patients who received any DAPD (n = 209) showed higher prevalence of comorbidity burdens and took more antihypertensive drugs compared with patients without DAPD. In patients taking DAPD, those with laterality index more than 4 had a higher prevalence of hypokalemia, a higher aldosterone-to-renin ratio and a higher prevalence of adrenal mass than those with laterality index of 4 or less. Adrenalectomy was performed in 76% patients with laterality index more than 4 and 20% with laterality index of 4 or less. Patients who underwent adrenalectomy showed biochemical cure in 89% with laterality index more than 4 and 50% with laterality index of 4 or less (P = 0.001). Multivariate regression analysis showed that laterality index more than 4 was an independent predictor of a biochemical cure. Biochemical cure rate in patients with laterality index more than 4 was consistently high, irrespective of the potential effect of individual DAPD on laterality index.Conclusion:Our findings suggest that in primary aldosteronism patients to whom DAPD were administrated due to severe clinical features, laterality index more than 4 in ACTH-AVS could accurately predict a biochemical cure after adrenalectomy.
AB - Objectives:Because of the influence on the renin-angiotensin-aldosterone system, it is recommended to avoid, if possible, the use of angiotensin-converting-enzyme inhibitors, angiotensin II type 1 receptor blockers, diuretics, β-blockers, and mineralocorticoid receptor antagonists during the diagnostic period of primary aldosteronism. A laterality index more than 4 in adrenocorticotropic hormone (ACTH)-stimulated adrenal venous sampling (ACTH-AVS) is a widely used classification of the unilateral subtype that can benefit from adrenalectomy. Here, we revealed clinical features of patients taking drugs that could affect the primary aldosteronism diagnosis (DAPD) and investigated whether the classification with laterality index more than 4 in ACTH-AVS is applicable to these patients.Patients and methods:Using a large database of primary aldosteronism patients in Japan, we analyzed 2122 patients with successful ACTH-AVS.Results:Patients who received any DAPD (n = 209) showed higher prevalence of comorbidity burdens and took more antihypertensive drugs compared with patients without DAPD. In patients taking DAPD, those with laterality index more than 4 had a higher prevalence of hypokalemia, a higher aldosterone-to-renin ratio and a higher prevalence of adrenal mass than those with laterality index of 4 or less. Adrenalectomy was performed in 76% patients with laterality index more than 4 and 20% with laterality index of 4 or less. Patients who underwent adrenalectomy showed biochemical cure in 89% with laterality index more than 4 and 50% with laterality index of 4 or less (P = 0.001). Multivariate regression analysis showed that laterality index more than 4 was an independent predictor of a biochemical cure. Biochemical cure rate in patients with laterality index more than 4 was consistently high, irrespective of the potential effect of individual DAPD on laterality index.Conclusion:Our findings suggest that in primary aldosteronism patients to whom DAPD were administrated due to severe clinical features, laterality index more than 4 in ACTH-AVS could accurately predict a biochemical cure after adrenalectomy.
KW - adrenal venous sampling
KW - adrenalectomy
KW - primary aldosteronism
KW - secondary hypertension
UR - http://www.scopus.com/inward/record.url?scp=85067266283&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067266283&partnerID=8YFLogxK
U2 - 10.1097/HJH.0000000000002047
DO - 10.1097/HJH.0000000000002047
M3 - Article
C2 - 31033727
AN - SCOPUS:85067266283
SN - 0263-6352
VL - 37
SP - 1493
EP - 1499
JO - Journal of hypertension
JF - Journal of hypertension
IS - 7
ER -